https://drugnews.com.tw/articles/2026-09-29-biotech-milestone-payments-formosa-pharmaengine-en.html Drugnews｜藥時事 en 2026-09-29T00:00:00.000Z Drug Approval in Hand—But Is the Cash in the Bank? How Formosa and PharmaEngine Turn Licensing Payments Into Cash https://drugnews.com.tw/articles/2026-09-29-biotech-milestone-payments-formosa-pharmaengine.html Drugnews｜藥時事 zh-tw 2026-09-29T00:00:00.000Z 藥證到手，錢就到帳？從台新藥、智擎看懂授權金怎麼變成現金 https://drugnews.com.tw/articles/2026-09-28-jnj-orthopaedics-separation-en.html Drugnews｜藥時事 en 2026-09-28T00:00:00.000Z US$9.2 Billion in Annual Sales—Why Does J&J Still Want to Separate Orthopaedics? https://drugnews.com.tw/articles/2026-09-28-jnj-orthopaedics-separation.html Drugnews｜藥時事 zh-tw 2026-09-28T00:00:00.000Z 年營收 92 億美元，強生為什麼還想把骨科拆出去？